- Home
- PNC vs SNY Comparison
PNC vs SNY Comparison
Compare PNC & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNC | SNY |
|---|---|---|
| Founded | 1852 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9B | 119.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PNC | SNY |
|---|---|---|
| Price | $222.71 | $46.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 6 |
| Target Price | ★ $220.26 | $61.50 |
| AVG Volume (30 Days) | 2.2M | ★ 2.7M |
| Earning Date | 01-16-2026 | 01-29-2026 |
| Dividend Yield | 3.05% | ★ 3.43% |
| EPS Growth | 20.86 | ★ 105.93 |
| EPS | ★ 16.61 | 8.67 |
| Revenue | $22,320,000,000.00 | ★ $53,890,648,839.00 |
| Revenue This Year | $13.22 | $1.73 |
| Revenue Next Year | $4.86 | $6.49 |
| P/E Ratio | $13.44 | ★ $10.59 |
| Revenue Growth | ★ 7.48 | N/A |
| 52 Week Low | $145.12 | $44.62 |
| 52 Week High | $227.00 | $60.12 |
Technical Indicators
Market Signals| Indicator | PNC | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 69.51 | 38.01 |
| Support Level | $209.53 | $46.68 |
| Resistance Level | $220.54 | $48.17 |
| Average True Range (ATR) | 4.07 | 0.65 |
| MACD | -0.37 | -0.09 |
| Stochastic Oscillator | 76.82 | 4.21 |
Price Performance
Historical ComparisonAbout PNC PNC Financial Services Group Inc. (The)
PNC Financial is one of the three super-regional banks in the US, with around $560 billion in total assets at the end of June 30, 2025. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 37% of revenue from fee income and 63% from net interest income in 2024.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.